KLEA HOLDING

PA:ALKLH France Diagnostics & Research
Market Cap
$55.22 Million
€53.80 Million EUR
Market Cap Rank
#23100 Global
#185 in France
Share Price
€0.18
Change (1 day)
-4.78%
52-Week Range
€0.17 - €0.30
All Time High
€0.30
About

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, Saudi Arabia, and the European Union. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. The company was formerly known as Visiom… Read more

KLEA HOLDING (ALKLH) - Total Assets

Latest total assets as of December 2024: €37.83 Million EUR

Based on the latest financial reports, KLEA HOLDING (ALKLH) holds total assets worth €37.83 Million EUR as of December 2024.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

KLEA HOLDING - Total Assets Trend (2010–2024)

This chart illustrates how KLEA HOLDING’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

KLEA HOLDING - Asset Composition Analysis

Current Asset Composition (December 2024)

KLEA HOLDING's total assets of €37.83 Million consist of 18.9% current assets and 81.1% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 8.7%
Accounts Receivable €3.53 Million 9.3%
Inventory €19.00K 0.1%
Property, Plant & Equipment €4.39 Million 11.6%
Intangible Assets €539.00K 1.4%
Goodwill €24.60 Million 65.0%

Asset Composition Trend (2010–2024)

This chart illustrates how KLEA HOLDING's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: KLEA HOLDING's current assets represent 18.9% of total assets in 2024, a decrease from 50.2% in 2010.
  • Cash Position: Cash and equivalents constituted 8.7% of total assets in 2024, up from 5.5% in 2010.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 66.0% of total assets, an increase from 28.0% in 2010.
  • Asset Diversification: The largest asset category is goodwill at 65.0% of total assets.

KLEA HOLDING Competitors by Total Assets

Key competitors of KLEA HOLDING based on total assets are shown below.

Company Country Total Assets
ADCNF
OTCGREY:ADCNF
USA $4.51 Billion
Berry Genomics Co Ltd
SHE:000710
China CN¥2.34 Billion
Malaysian Genomics Resource
KLSE:0155
Malaysia RM20.70 Million
NSN Co. Ltd
KQ:031860
Korea ₩60.96 Billion
JOONGANG DNM Co.Ltd
KQ:051980
Korea ₩121.79 Billion
GeneMatrix Inc
KQ:109820
Korea ₩28.03 Billion
Genoray Co. Ltd
KQ:122310
Korea ₩125.67 Billion
Green Cross Lab Cell Corporation
KQ:144510
Korea ₩565.79 Billion

KLEA HOLDING - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.16 - 3.21

Moderate asset utilization - KLEA HOLDING generates 0.46x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -163.28% - 3.71%

Moderate ROA - For every $100 in assets, KLEA HOLDING generates $ 3.71 in net profit.

KLEA HOLDING - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.01 1.56 0.82
Quick Ratio 2.01 1.56 0.63
Cash Ratio 0.00 0.00 0.00
Working Capital €3.59 Million € 1.90 Million € -2.92 Million

KLEA HOLDING - Advanced Valuation Insights

This section examines the relationship between KLEA HOLDING's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.62
Latest Market Cap to Assets Ratio 0.89
Asset Growth Rate (YoY) 3.4%
Total Assets €37.83 Million
Market Capitalization $33.56 Million USD

Valuation Analysis

Near Book Valuation: The market values KLEA HOLDING's assets close to their book value ( 0.89x), suggesting investors view the company's assets at approximately fair value.

Positive Asset Growth: KLEA HOLDING's assets grew by 3.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for KLEA HOLDING (2010–2024)

The table below shows the annual total assets of KLEA HOLDING from 2010 to 2024.

Year Total Assets Change
2024-12-31 €37.83 Million +3.36%
2023-12-31 €36.60 Million +1.42%
2022-12-31 €36.09 Million -18.12%
2021-12-31 €44.07 Million +645.79%
2020-12-31 €5.91 Million -59.89%
2019-12-31 €14.73 Million -20.48%
2018-12-31 €18.52 Million -8.00%
2017-12-31 €20.14 Million +3.75%
2016-12-31 €19.41 Million +0.74%
2015-12-31 €19.27 Million +28.37%
2014-12-31 €15.01 Million +18.96%
2013-12-31 €12.62 Million -2.29%
2012-12-31 €12.91 Million -16.30%
2011-12-31 €15.43 Million +17.66%
2010-12-31 €13.11 Million --